MAP2K7 and depressive symptom measurement: Because haploinsufficiency and conditional MAP2K7 gene deletion were associated with lymphocyte hyperproliferation, schizophrenia, neuropathy, and depression, systemic MAP2K7 inhibition may cause side effects due to off-tissue activity.